BIOMOTIV
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and Development. The Harrington Project, unveiled in February by University Hospitals (UH), is a first-of-its-kind $250 million initiative that promises to revolutionize how new breakthrough drugs are advanced to market. By aligning the upstream efforts of the recently created UH Case Medical Center’s Harrington Discovery Institute with the downstream development efforts of BioMotiv, The Harrington Project seeks to accelerate the therapeutic innovation process for the benefit of patients globally. The company was founded in 2012 and is headquartered in Cleveland, Ohio.
BIOMOTIV
Social Links:
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2012-01-01
Status:
Active
Contact:
216-455-3200
Email Addresses:
[email protected]
Total Funding:
166.83 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Domain Not Resolving Global Site Tag
Similar Organizations
Huntington Memorial Research Institute
Huntington Medical Research Institutes specializes in biotech and life sciences.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Investors List
Takeda Ventures
Takeda Ventures investment in Venture Round - BioMotiv
Nationwide Mutual Capital
Nationwide Mutual Capital investment in Venture Round - BioMotiv
Harrington Family
Harrington Family investment in Venture Round - BioMotiv
University Hospitals
University Hospitals investment in Venture Round - BioMotiv
University Hospitals
University Hospitals investment in Venture Round - BioMotiv
Harrington Family
Harrington Family investment in Venture Round - BioMotiv
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-17 | Amphista Therapeutics | BioMotiv investment in Series B - Amphista Therapeutics | 53 M USD |
| 2021-01-05 | Aro Biotherapeutics | BioMotiv investment in Series A - Aro Biotherapeutics | 88 M USD |
| 2020-04-07 | Amphista Therapeutics | BioMotiv investment in Series A - Amphista Therapeutics | 7.5 M USD |
| 2018-12-11 | Aro Biotherapeutics | BioMotiv investment in Venture Round - Aro Biotherapeutics | 13 M USD |
| 2017-01-27 | Allinaire Therapeutics | BioMotiv investment in Seed Round - Allinaire Therapeutics | 1.57 M USD |
| 2014-04-28 | Orca Pharmaceuticals | BioMotiv investment in Venture Round - Orca Pharmaceuticals | 1.3 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-05 | BioMotiv announces appointment of Satish Jindal as CEO |